Catalyst Wire Dossier Catalyst Wire Dossier

Nateglinide/Metformin HCl Combined Tablet

· IlDong Pharmaceutical Co Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nateglinide/Metformin HCl Combined Tablet, covering 2014-03-17 to 2014-03-17. Get the full timeline:

Most recent: Clinical Trial Update: A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects [Phase 1]

See pricing